Patent · US Active

Chemical compounds having antiviral activity against Dengue virus and other Flaviviruses

US8722742B2 · kind B2 · utility

11Cited by

0References

1Claims

0Family size

Assignee

CENTRO DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA · CU

Inventors

Yuliet Mazola Reyes · Havana, CU
Glay Chinea Santiago · Havana, CU
Osmany Guirola Cruz · Boyeros, CU
Roberto Vera Alvarez · Boyeros, CU
Vivian Huerta Galindo · Boyeros, CU
Noralvis Fleitas Salazar · Havana, CU
Alexis Musacchio Lasa · Boyeros, CU

Key dates

Filing date	Feb 27, 2009
Grant date	May 13, 2014
Priority date	—
Expiry date	Sep 9, 2030

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Use of chemical compounds obtained in silico for the preparation of pharmaceutical compositions to attenuate or inhibit Dengue virus infection. Particularly, through the interference or the modulation of several stages of viral replication cycle related with the entry of virus into host cells and the assembly of mature progeny virions. The invention also comprises the use of such pharmaceutical compositions for prophylactic and/or therapeutic treatment of infection caused by all four serotypes of Dengue virus and other flaviviruses.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.